Detalhe da pesquisa
1.
RAF inhibitor re-challenge therapy in BRAF-aberrant pan-cancers: the RE-RAFFLE study.
Mol Cancer
; 23(1): 64, 2024 03 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-38532456
2.
Safety and Efficacy of Immune Checkpoint Inhibitors in Patients with Cancer and Viral Hepatitis: The MD Anderson Cancer Center Experience.
Oncologist
; 28(8): 714-721, 2023 08 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36952233
3.
Adoptive cell therapy in gynecologic cancers: A systematic review and meta-analysis.
Gynecol Oncol
; 165(3): 664-670, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35400527
4.
Preoperative variables associated with transfusion requirements in orthotopic liver transplantation.
Transfus Apher Sci
; 50(1): 99-105, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24291115
5.
Clinical and genomic landscape of RAS mutations in gynecologic cancers.
Clin Cancer Res
; 2024 Apr 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38687597
6.
Histological transformation to gliosarcoma with combined BRAF/MEK inhibition in BRAF V600E mutated glioblastoma.
NPJ Precis Oncol
; 7(1): 47, 2023 May 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-37231247
7.
Strategies for mitigating adverse events related to selective RET inhibitors in patients with RET-altered cancers.
Cell Rep Med
; 4(12): 101332, 2023 12 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-38118420
8.
Spectrum of Immune Checkpoint Inhibitor Anemias: Results From a Single Center, Early-Phase Clinical Trials Case Series Experience.
J Hematol
; 11(3): 113-120, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35837373
9.
Associação Brasileira de Hematologia, Hematologia, Hemoterapia e Terapia Celular Consensus on genetically modified cells. Review article: Cell therapy in solid tumors.
Hematol Transfus Cell Ther
; 43 Suppl 2: S78-S83, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-34794801
10.
Prognostic Value of Systemic Inflammatory Biomarkers in Patients with Metastatic Renal Cell Carcinoma.
Pathol Oncol Res
; 26(4): 2489-2497, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32583330
11.
Primary splenic angiosarcoma: a rare entity often associated with rupture and hemoperitoneum.
Autops Case Rep
; 9(3): e2019100, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31372360
12.
Real-world evidence on first-line treatment for metastatic renal cell carcinoma with non-clear cell and sarcomatoid histologies: are sunitinib and pazopanib interchangeable?
Ecancermedicalscience
; 13: 973, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31921344
13.
Learning From Failure: Negative Trials in Oncology.
J Immunother Precis Oncol
; 6(2): 59-60, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-37214208
14.
Analysis of Efficacy and Toxicity Profile of First-Line Sunitinib or Pazopanib in Metastatic Clear Cell Renal Cell Carcinoma in the Brazilian Population.
J Glob Oncol
; 4: 1-10, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30199304
15.
Cannabidiol reverses the mCPP-induced increase in marble-burying behavior.
Fundam Clin Pharmacol
; 28(5): 544-50, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-24118015
16.
Hemoglobin concentration increment is associated with a better prognosis in HIV patients with anemia.
Int J Infect Dis
; 16(9): e703, 2012 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-22698887